Authors :
M. H. Farahat; Y. T. Allam
Volume/Issue :
Volume 8 - 2023, Issue 9 - September
Google Scholar :
https://tinyurl.com/5ezp2rdb
Scribd :
https://tinyurl.com/yc7c4wbx
DOI :
https://doi.org/10.5281/zenodo.10007471
Abstract :
Open-wound complications - ranging from
mild infections to amputations and organ failures- claim
the lives of approximately 5 million people annually[5]
.
Surgical intervention remains the primary treatment for
wound-caused severe bleeding, but access to healthcare
is limited in many parts of the world, necessitating the
development of alternative mobile solutions. This
research projectaimed to address this issue by designing
a bandage tailored for the treatment of severe bleeding
and wound recovery. Utilizing phytohemagglutinin
(PHA) protein and chitosan, the bandage exhibited
exceptional wound healing rates as well as infections
prevention in both the in vitro and in vivo trials,
showcasing it as a promising solution for wound
management and haemorrhage control in diverse
healthcare settings.
Open-wound complications - ranging from
mild infections to amputations and organ failures- claim
the lives of approximately 5 million people annually[5]
.
Surgical intervention remains the primary treatment for
wound-caused severe bleeding, but access to healthcare
is limited in many parts of the world, necessitating the
development of alternative mobile solutions. This
research projectaimed to address this issue by designing
a bandage tailored for the treatment of severe bleeding
and wound recovery. Utilizing phytohemagglutinin
(PHA) protein and chitosan, the bandage exhibited
exceptional wound healing rates as well as infections
prevention in both the in vitro and in vivo trials,
showcasing it as a promising solution for wound
management and haemorrhage control in diverse
healthcare settings.
